CARLSBAD, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the ...
Brigham researchers found people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms. A persistent ...
For the first time in the world, a device, developed by Sharp Corporation, equipped with Plasmacluster technology, which ...
Research reveals a sharp decline in both the effectiveness and duration of protection from prior infection post-Omicron, underscoring the need for updated vaccines to sustain immunity Study: ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Nearly 85% of people with long COVID had experienced ...
Five years after SARS-CoV-2 triggered a worldwide pandemic, leading to widespread devastation, another bat-borne coronavirus ...
UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...
It’s that time of year: a thick, oppressive heat blankets everything, people huddle inside air-conditioned homes, offices, shops and cafes for respite—and COVID is surging again. Levels of SARS-CoV-2, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results